SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Venus Remedies gets marketing approval for cancer drugs from Uzbekistan, Palestine

22 Feb 2023 Evaluate

Venus Remedies has received marketing authorisations for its generic cancer drugs from Uzbekistan and Palestine. Having over 800 marketing authorizations worldwide, the company is making big strides by extending its footprint in Central Asia and Middle East with the marketing approval for Carboplatin in Uzbekistan and Docetaxel and Irinotecan in Palestine. These countries have limited access to quality medicines, and Venus Remedies is expected to launch these drugs in the two countries in the next financial year.

These marketing authorisations have further strengthened the company's commitment to providing cost-effective generic alternatives to expensive branded drugs and improving access to affordable Medicines to cancer patients in need. With these marketing approvals, the three generic cancer drugs signifying advances in cancer treatment will considerably benefit thousands of patients as well as the broader healthcare community.

Venus Remedies is one of the handful player in pharmaceutical sector to launch world global injectable manufacturers. It has world-class manufacturing facilities in Panchkula and Baddi (in India) and Werne (in Germany) and research and development center in Venus Medicine Research Centre (in India).

Venus Remedies Share Price

1042.35 3.25 (0.31%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×